DGAP-News: ABIVAX
/ Key word(s): Study
Abivax phase 3 program with obefazimod in ulcerative colitis progresses with US IRB approval
04.08.2022 / 18:00
The issuer is solely responsible for the content of this announcement.
ABIVAX PHASE 3 PROGRAM WITH...
Quelle: Börse Online RSS Feed
|